Legal & General Group PLC Celularity Inc Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.56 - $1.15 $6,874 - $14,117	-12,276 Reduced 60.58%	7,988 $4,000
Q4 2022 Feb 14, 2023	BUY	$1.08 - $2.35 $5,848 - $12,725	5,415 Added 36.47%	20,264 $26,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $2,690 - $26,963	6,256 Added 72.8%	14,849 $34,000
Q2 2022 Aug 22, 2022	BUY	$2.81 - $12.91 $24,146 - $110,935	8,593 New	8,593 $29,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $296M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.